Cargando…

Adaptive designs for phase II cross-over dose-finding trials using Bayesian model averaging

Detalles Bibliográficos
Autores principales:	Simpson, Sarah, Hampson, Lisa, Jaki, Thomas, Jones, Byron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660065/ http://dx.doi.org/10.1186/1745-6215-16-S2-P148

Ejemplares similares

A pragmatic approach to the design and calibration of a Bayesian CRM dose finding trial
por: Cole, Michael, et al.
Publicado: (2015)

Innovative considerations on a phase 2a dose-finding strategy using Bayesian methods and MCP-MOD
por: Bedding, Alun, et al.
Publicado: (2015)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

Average findings of uric acid in blood in patients with gout with different categories of hyperglycemia
por: Kayumov, Ulugbek K, et al.
Publicado: (2012)

A novel Bayesian method for dual-agent Phase I dose-escalation studies using penalized D-optimality
por: Wheeler, Graham
Publicado: (2013)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation
por: Koenig, Franz, et al.
Publicado: (2015)

The importance of planning for a seamless transition in an adaptive phase II randomised trial
por: Marshall, Andrea, et al.
Publicado: (2011)

Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic
por: Ewings, Sean, et al.
Publicado: (2022)

An integrated approach to the development of a Bayesian response-adaptive dose-finding study using sas and winbugs
por: Hansen, Christian Holm, et al.
Publicado: (2013)

Practical implementation of an adaptive phase I/II design in chronic myeloid leukaemia: evaluating both efficacy and toxicity using the EffTox design
por: Khan, Josephine, et al.
Publicado: (2013)

SCI: A Bayesian adaptive phase I/II dose‐finding design accounting for semi‐competing risks outcomes for immunotherapy trials
por: Zhang, Yifei, et al.
Publicado: (2022)

Experiences in the design and implementation of phase II trials in CLL
por: Cohen, Dena R, et al.
Publicado: (2011)

Directions vs. averages: an in-vivo comparison for cardiac DTI
por: Scott, Andrew D, et al.
Publicado: (2015)

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma
por: Atkins, Michael B, et al.
Publicado: (2015)

Recruitment progression rules for internal pilot studies monitoring recruitment
por: Hampson, Lisa, et al.
Publicado: (2015)

Assessment of energy loss in aortic stenosis using Bayesian multipoint phase-contrast MRI
por: Binter, Christian, et al.
Publicado: (2013)

A Bayesian adaptive design for clinical trials in rare diseases
por: Williamson, S. Faye, et al.
Publicado: (2017)

The use of Bayesian design in two trials in rare cancers
por: Dutton, Peter, et al.
Publicado: (2015)

Subgroup‐specific dose finding for phase I‐II trials using Bayesian clustering
por: Curtis, Alexandra, et al.
Publicado: (2022)

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013)

Unifying low-level mechanistic and high-level Bayesian explanations of bistable perceptions: neuronal adaptation for cortical inference
por: Reichert, David P, et al.
Publicado: (2011)

Adaptive dose-finding designs to identify multiple doses that achieve multiple response targets
por: Bond, Simon, et al.
Publicado: (2013)

A discussion of an issue relating to sample sizes of exact phase II trial designs
por: Howman, Andrew
Publicado: (2013)

Bayesian model averaging for nonparametric discontinuity design
por: Hinne, Max, et al.
Publicado: (2022)

Renal biopsy findings in children with FMF in Armenia: trends over the study period
por: Papazyan, M, et al.
Publicado: (2015)

Association between average glucose levels and hospital mortality among critically ill patients
por: Yegneswaran, B, et al.
Publicado: (2013)

Does average volume-assured pressure support make any difference compared with BIPAP?
por: Canpolat, G, et al.
Publicado: (2014)

Evaluation of APACHE II, SAPS II and sofa as predictors of mortality in patients over 80 years admitted to ICU
por: Romo Gonzales, JE, et al.
Publicado: (2015)

Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
por: Wilson, Duncan T, et al.
Publicado: (2015)

Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
por: Napoletano, Chiara, et al.
Publicado: (2013)

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

Bayesian inference from single spikes
por: Monk, Travis, et al.
Publicado: (2013)

Bayesian entropy estimators for spike trains
por: Park, Il Memming, et al.
Publicado: (2013)

How Cancer Research UK is adapting to adaptive designs
por: Hearn, Julie, et al.
Publicado: (2011)

Left and right ventricular kinetic energy using time-resolved versus time-average ventricular volumes
por: Hussaini, Syed F, et al.
Publicado: (2015)

Information-theoretic model averaging: a useful method for modelling exploratory secondary endpoints in clinical trials
por: Lythgoe, Daniel
Publicado: (2013)

P035 Is the Grael oximetry averaging time interchangeable with a Masimo pulse oximeter algorithm in polysomnography?
por: Eritaia, J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4fuvnlk12thj0d32i8fmo0snbf